Ernexa Therapeutics Inc.ERNANASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank33
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P33
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -22.23% |
| 2023 | -43.03% |
| 2022 | -18.21% |
| 2021 | 221.56% |
| 2020 | 15096.15% |
| 2019 | -63.89% |
| 2018 | -48.20% |
| 2017 | 0.00% |
| 2016 | 0.00% |
| 2015 | 0.00% |